Association between the IL1B, IL1RN polymorphisms and COPD risk: A meta-analysis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Xie, Zi Kang ^a   Huang, Qiu Pin ^a   Huang, Jian ^a   Xie, Zheng Fu ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IL1B PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ASIAN CONTINENTAL ANCESTRY GROUP; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HOMOZYGOTE; HUMAN; META ANALYSIS; RISK;

ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; ODDS RATIO; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK;

EID: 84906860979     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06202     Document Type: Article

References (36)

1. Decramer, M., Janssens, W. & Miravitlles, M. Chronic obstructive pulmonary disease. Lancet. 379, 1341-1351 (2012).
2. Molfino, N. A. Current thinking on genetics of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 13, 107-113 (2007). (Pubitemid 46175106)
3. Bossé, Y. Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis. 7, 607-631 (2012).
4. Zhou, H. et al. Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis. Sci Rep. 3, 2818 (2013).
5. Dinarello, C. A. Interleukin-1. Cytokine Growth Factor Rev. 8, 253-265 (1997).
6. Nicklin, M. J., Weith, A. & Duff, G. W. Aphysical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, andinterleukin-1 receptor antagonist genes. Genomics. 19, 382-384 (1994). (Pubitemid 24059336)
7. Luomala, M. et al. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. J Neurol Sci. 185, 123-127 (2001). (Pubitemid 32318517)
8. Shete, A. R., Joseph, R., Vijayan, N. N., Srinivas, L. & Banerjee, M. Association of single nucleotide gene polymorphism at interleukin-1beta 13954, -511, and -31 in chronic periodontitis and aggressive periodontitis in Dravidian ethnicity. J Periodontol. 81, 62-69 (2010).
9. MANTEL, N. & HAENSZEL, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22, 719-748 (1959).
10. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials. 7, 177-188 (1986). (Pubitemid 17189972)
11. Ishii, T. et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med. 94, 847-851 (2000).
12. Hegab, A. E. et al. Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease. Biochem Biophys Res Commun. 329, 1246-1252 (2005). (Pubitemid 40568703)
13. Broekhuizen, R. et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism. Am J Clin Nutr. 82, 1059-1064 (2005). (Pubitemid 43779765)
14. Shi, Y. Z., Liu, B., Huo, J. M. & Zhang, W. Relationship between interleukin-1 cytokine gene polymorphisms and genetic susceptibility to chronic obstructive pulmonary diseases. Zhongguo Lin Chuang Kang Fu. 10, 67-69 (2006).
15. Hsieh, M. H. et al. Lack of associations between several polymorphisms in cytokine genes and the risk ofchronic obstructive pulmonary diseases in Taiwan. Kaohsiung J Med Sci. 24, 126-137 (2008).
16. Lee, J. M. et al. Polymorphisms in interleukin-1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: a case-control study. Respir Med. 102, 1311-1320 (2008).
17. Liu, Y. Q., Liu, X. Y., Li, H. F. & Wang, L. H. Relationship between polymorphism of IL-1b gene and chronic obstructive pulmonary disease in Han population. Zhongguo Man Xing Bing Yu Fang Yu Kong Zhi. 20, 128-131 (2012).
18. Shukla, R. K., Kant, S., Bhattacharya, S. & Mittal, B. Association of cytokine gene polymorphisms in patients with chronic obstructive pulmonary disease. Oman Med J. 27, 285-290 (2012).
19. Liu, Y. Q., Wang, L. H., Liu, X. Y. & Li, H. F. Association study between polymorphism of IL1b-31T/C,-511C/T and chronic obstructive pulmonary disease. Zhongguo Zong He Lin Chuang. 29, 1169-1173 (2013).
20. Sun, L. R. et al. Relationship between the genetic polymorphism of IL-1, IL-6 and pulmonary hypertension in patient with COPD. Yi Xue Yan Jiu Za Zhi. 42, 80-84 (2013).
21. Issac, M. S., Ashur, W. & Mousa, H. Genetic Polymorphisms of Surfactant Protein D rs2243639, Interleukin (IL)-1b rs16944 and IL-1RN rs2234663 in Chronic Obstructive Pulmonary Disease, Healthy Smokers, and Non-Smokers. Mol Diagn Ther, 10. 1007/s40291-014-0084-5 (2014).
22. Botelho, F. M. et al. Innate immune processes are sufficient for driving cigarette smoke-induced inflammation in mice. Am J Respir Cell Mol Biol. 42, 394-403 (2010).
23. Kuschner, W. G., D'Alessandro, A., Wong, H. & Blanc, P. D. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 9, 1989-1994 (1996). (Pubitemid 26333532)
24. Rusznak, C. et al. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of neversmokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 23, 530-536 (2000).
25. Sapey, E. et al. Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD. J Clin Immunol. 29, 508-516 (2009).
26. Bafadhel, M. et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. AmJ Respir Crit Care Med. 184, 662-671 (2011).
27. El-Omar, E. M. et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature. 412, 99 (2001).
28. Kim, S. H., Mok, J. W., Kim, H. S. & Joo, C. K. Association of -31T. C and -511 C. T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Mol Vis. 14, 2109-2116. (2008).
29. Danis, V. A., Millington, M., Hyland, V. J. & Grennan, D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. Clin Exp Immunol. 99, 303-310 (1995).
30. Santtila, S., Savinainen, K. & Hurme, M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 47, 195-198 (1998). (Pubitemid 28153395)
31. Witkin, S. S., Gerber, S. & Ledger, W. J. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 34, 204-209 (2002). (Pubitemid 34028353)
32. van der Paardt, M. et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford). 41, 1419-1423 (2002).
33. Lee, S. H. et al. Polymorphisms in interleukin-1 beta and Interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am J Nephrol. 24, 410-414 (2004). (Pubitemid 39279382)
34. Tountas, N. A. et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 117, 806-813 (1999). (Pubitemid 29468222)
35. Feakes, R. et al. Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis. J Neuroimmunol. 105, 96-101 (2000). (Pubitemid 30125434)
36. Joos, L. et al. Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax. 56, 863-866 (2001). (Pubitemid 32999834)